| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
From the Departments of Ophthalmology*
and
Dermatology,
Kyoto Prefectural University of
Medicine, Kyoto, Japan
In Stevens-Johnson syndrome, pathological keratinization of the ordinarily nonkeratinized corneal and conjunctival mucosal epithelia results in severe visual loss. We examined conjunctiva covering cornea in five eyes in the chronic cicatricial phase of Stevens-Johnson syndrome. Normal conjunctiva from five age-matched individuals was studied also. The number of epithelial cells in Stevens-Johnson syndrome conjunctiva that were immunoreactive with a monoclonal antibody, Ki-67, to a nuclear antigen found only in proliferating cells was greater than normal (93.8 ± 19.8 cells above 100 basal cells versus 12.8 ± 0.5 cells above 100 basal cells; P = 0.009). In addition, although clinical inflammation was mild, massive lymphocytic infiltration was seen in the substantia propria of conjunctiva covering cornea. In situ hybridization documented transglutaminase 1 (keratinocyte transglutaminase) mRNA in suprabasal cells of the abnormally thickened conjunctival epithelium in all Stevens-Johnson syndrome patients. In contrast, no message was detected in normal conjunctival or corneal epithelia. Transglutaminase 1 is expressed during the terminal differentiation of keratinocytes where it helps synthesize cornified cell envelopes. We speculate that in Stevens-Johnson syndrome, epithelial hyperproliferation, and transglutaminase 1 gene expression lead to the pathological keratinization of ocular surface mucosal epithelia.
This article has been cited by other articles:
 |
|
 |
|
  S. Li, K. Nikulina, J. DeVoss, A. J. Wu, E. C. Strauss, M. S. Anderson, and N. A. McNamara Small Proline-Rich Protein 1B (SPRR1B) Is a Biomarker for Squamous Metaplasia in Dry Eye Disease Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, Y. Hayashida, Y.-T. Chen, H. He, D. Y. Tseng, M. Alonso, S.-Y. Chen, X. Xi, and S. C. G. Tseng Air Exposure Induced Squamous Metaplasia of Human Limbal Epithelium Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 154 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priglinger, C. S. Alge, T. C. Kreutzer, A. S. Neubauer, C. Haritoglou, A. Kampik, and U. Welge-Luessen Keratinocyte Transglutaminase in Proliferative Vitreoretinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4990 - 4997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakamura, K. Nishida, A. Dota, and S. Kinoshita Changes in Conjunctival Clusterin Expression in Severe Ocular Surface Disease Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1702 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakamura, K. Nishida, A. Dota, M. Matsuki, K. Yamanishi, and S. Kinoshita Elevated Expression of Transglutaminase 1 and Keratinization-Related Proteins in Conjunctiva in Severe Ocular Surface Disease Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 549 - 556. [Abstract] [Full Text]
|
|
|
|
|
|
T. Senoo and N. C. Joyce Cell Cycle Kinetics in Corneal Endothelium from Old and Young Donors Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 660 - 667. [Abstract] [Full Text]
|
|
|
|
|
|
M. Raghunath, R. Cankay, U. Kubitscheck, J. D. Fauteck, R. Mayne, D. Aeschlimann, and U. Schlotzer-Schrehardt Transglutaminase Activity in the Eye: Cross-linking in Epithelia and Connective Tissue Structures Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 2780 - 2787. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
